Overview

Temozolomide and Radiation Therapy in Treating Young Patients With Pontine Glioma

Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy, such as temozolomide, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Radiation therapy uses high-energy x-rays to kill tumor cells. Giving temozolomide together with radiation therapy may kill more tumor cells. PURPOSE: This phase II trial is studying how well giving temozolomide together with radiation therapy works in treating young patients with pontine glioma.
Phase:
Phase 2
Details
Lead Sponsor:
Children's Cancer and Leukaemia Group
Treatments:
Dacarbazine
Motexafin gadolinium
Temozolomide